Ultra Drugs Private Limited - Company Profile

It is a pharma private limited company based in Chandigarh, Chandigarh, India, established in 2005.
2005 Chandigarh, Chandigarh, India Active
Last Updated:
Access Report
About Ultra Drugs Private Limited

Ultra Drugs Private Limited, a active private limited company, was established on 03 October 2005 in Chandigarh, Chandigarh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230CH2005PTC029023. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹3.50 Cr and a paid-up capital of ₹3.06 Cr.

It upholds a compliant status. Employing 506 professional, Its leadership includes Sandeep Kumar Arora (Director), Minna Jakhar (Director), Sangram Singh (Director). Past directors included Banshidhar Kanhaiyalal, Rajinder Kaur, Malwinderjit Singh Waraich. It holds ₹41.90 Cr open charges and ₹26.77 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H.No. 1201 Sector-22 B, Chandigarh, Chandigarh, 160022.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230CH2005PTC029023

  • Registration Number

    029023

  • Incorporation Date

    03 October 2005

  • Authorized Capital

    ₹3.50 Cr

  • Paid-Up Capital

    ₹3.06 Cr

  • ROC Code

    Roc Chandigarh

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.50 Cr
  • Paid Up Capital ₹ 3.06 Cr
  • Company Age 20 Year, 5 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 41.90 Cr
  • Satisfied Charges ₹ 26.77 Cr
  • Revenue Growth **** 4.20%
  • Profit Growth **** -47.18%
  • Ebitda **** -20.65%
  • Net Worth 7.96%
  • Total Assets **** 13.75%
Company report

Ultra Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Ultra Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Ultra Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Sandeep Kumar Arora Director 20 Jan 2019 Current
Minna Jakhar Director 14 Jan 2008 Current
Sangram Singh Director 30 Jun 2015 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 14 Jan 2008 Past
Pramod Abcsdd Director 19 Aug 2014 Past
Pramod Abcsdd Director 20 Jan 2019 Past
Pramod Abcsdd Director 26 Sep 2018 Past
Pramod Abcsdd Additional Director 23 Feb 2008 Past
Pramod Abcsdd Additional Director 23 Feb 2008 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ultra Drugs.

Ultra Drugs Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.2% increase. The company also saw a substantial fall in profitability, with a 47.18% decrease in profit. The company's net worth moved up by a moderate rise of 7.96%.

Ultra Drugs revenue growth over time
Ultra Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 4.20%
*******
*******
*******
*******
Revenue from Operations
*******
 4.31%
*******
*******
*******
*******
Total Assets
*******
 13.75%
*******
*******
*******
*******
Profit or Loss
*******
 -47.18%
*******
*******
*******
*******
Net Worth
*******
 7.96%
*******
*******
*******
*******
EBITDA
*******
 -20.65%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ultra Drugs?

In 2023, Ultra Drugs had a promoter holding of 100.00%. The company had 3 Subsidiaries and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹419,000,000.00

Satisfied Charges

₹267,699,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 23.10 Cr
  • State Bank Of India : 18.50 Cr
  • Director Of Industries Himachal Pradesh : 0.30 Cr
Latest Charge Details
Date Lender Amount Status
24 Jan 2023 State Bank Of India ₹18.50 Cr Open
29 Aug 2021 Hdfc Bank Limited ₹1.00 Cr Open
03 Mar 2021 Hdfc Bank Limited ₹1.00 M Open
28 Dec 2019 Hdfc Bank Limited ₹22.00 Cr Open
28 May 2011 Director Of Industries Himachal Pradesh ₹3.00 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Ultra Drugs?

Ultra Drugs has a workforce of 506 employees as of Sep 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ultra Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ultra Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ultra Drugs
Recent Activity within the Organization
  • Charges

    A charge with Hdfc Bank Limited of Rs. 22.00 Cr registered on 28 Dec 2019 with Charge ID 100320405 was modified on 26 Nov 2025. was recorded as a recent event.

  • Charges

    The activity A charge with State Bank Of India of Rs. 18.50 Cr registered on 24 Jan 2023 with Charge ID 100685124 was modified on 03 May 2025. was completed.

  • Annual General Meeting

    Progress on Ultra Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Ultra Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh. was completed.

  • Charges

    The activity A charge with State Bank Of India amounted to Rs. 18.50 Cr with Charge ID 100685124 was registered on 24 Jan 2023. was completed.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 1.00 Cr with Charge ID 100487596 was registered on 29 Aug 2021. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Ultra Drugs Private Limited?

The CIN of Ultra Drugs Private Limited is U24230CH2005PTC029023.

Where is Ultra Drugs Private Limited headquartered?

Ultra Drugs Private Limited is headquartered at H.No. 1201 Sector-22 B, Chandigarh, Chandigarh, 160022.

When was Ultra Drugs Private Limited incorporated?

Ultra Drugs Private Limited was incorporated on 03 October 2005.

Who are the current directors of Ultra Drugs Private Limited?

The current directors of Ultra Drugs Private Limited are

What is the primary industry of Ultra Drugs Private Limited?

The primary industry of Ultra Drugs Private Limited is Manufacturing.

Is Ultra Drugs Private Limited a listed company?

Ultra Drugs Private Limited is unlisted.

What is the capital structure of Ultra Drugs Private Limited?

The authorized capital of Ultra Drugs Private Limited is ₹3.50 Cr, and the paid-up capital is ₹3.06 Cr.

What is the compliance status of Ultra Drugs Private Limited?

The compliance status of Ultra Drugs Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available